[
    "{\"step_by_step_thinking\": \"Figitumumab is a type of monoclonal antibody that was being developed for the treatment of various types of cancer, including non-small cell lung cancer. However, in clinical trials, it was found to be ineffective and even potentially harmful, leading to the discontinuation of its development.\", \"answer_choice\": \"B. no\"}"
]